Provider-Focused Intervention for Maximizing HPV Vaccine Uptake in Young Cancer Survivors

Completed · Not applicable

Conditions studied: Papillomavirus Vaccines

In brief

The focus of this research is on increasing the uptake of the human papillomavirus (HPV) vaccine in young cancer survivors, a vulnerable population at high risk for developing new cancers (such as cervical and anal cancer) caused by persistent HPV infection. An effective vaccine exists that can prevent these cancers, but HPV vaccine uptake is low among young cancer survivors. This research will evaluate the effectiveness and implementation of an evidence-based intervention, adapted for use by healthcare providers in pediatric oncology clinics, to increase the uptake of HPV vaccine among young cancer survivors 9-17 years of age. Results of this research will provide important information that can be used to implement new strategies to increase the uptake of the HPV vaccine among young cancer survivors.

Key facts

Study ID
NCT04469569
Run by
University of Alabama at Birmingham
People needed
8120
Starts
2021-02-01
Expected to finish
2025-12-15
Last updated by the study team
2026-08-03

Who can join

Age: 9 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.